Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MILESTONE SCIENTIFIC INC. Director's Dealing 2017

Jan 11, 2017

34735_dirs_2017-01-11_130f76ca-2b2e-4971-9b1b-fadfdfa9c1cd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MILESTONE SCIENTIFIC INC. (MLSS)
CIK: 0000855683
Period of Report: 2017-01-09

Reporting Person: OSSER LEONARD (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-01-09 Common Stock M 83333 $0.75 Acquired 3070568 Direct
2017-01-09 Common Stock A 31056 Acquired 3101624 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-01-09 Options to purchase Common stock $0.75 M 83333 Disposed 2017-01-09 Common stock (83333) Direct
2017-01-09 Options to purchase Common stock $1.77 A 62112 Acquired 2022-01-09 Common Stock (62112) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Options to purchase Common stock $1.9300 2021-12-02 Common stock (171429) 171429 Direct
Options to purchase Common stock $1.6500 2018-12-31 Common stock (248448) 248448 Direct
Options to purchase Common stock $1.4900 2019-11-01 Common stock (73333) 73333 Direct
Options to purchase Common stock $2.3800 2019-11-01 Common stock (185185) 185185 Direct
Options to purchase Common stock $3.4900 2020-06-20 Common stock (57307) 57307 Direct
Options to purchase Common stock $1.8900 2021-02-04 Common stock (82988) 82988 Direct

Footnotes

F1: 910,196 shares are issuable to the reporting person at the termination of employment.

F2: These options are exercisable as follows: (i) for 57,143 shares on the date of grant (12-2-16) and (ii) for an additional 1/3 of the 114,286 remaining shares on each of the 1st through 3rd anniversaries of the date of grant.

F3: Not applicable.

F4: These options are exercisable as follows: (i) immediately for 193,210 and (ii) for an additional 55,238 on 12/31/16.

F5: These options are exercisable as follows: (i) for 61,728 shares on the date of grant (11-20-14) and (ii) for an additional 1/3 of the 123,457 remaining shares on each of the 1st through 3rd anniversaries of the date of grant.

F6: These options are exercisable as follows: (i) for 19,102 shares on the date of grant (6-20-15) and (ii) for an additional 1/3 of the 38,205 remaining shares on each of the 1st through 3rd anniversaries of the date of grant.

F7: These options are exercisable as follows: (i) for 27,663 shares on the date of grant (2-4-16) and (ii) for an additional 1/3 of the 55,325 remaining shares on each of the 1st through 3rd anniversaries of the date of grant.

F8: These options are exercisable as follows: (i) for 20,704 shares on the date of grant (1-9-17) and (ii) for an additional 1/3 of the 41,408 remaining shares on each of the 1st through 3rd anniversaries of the date of grant.